Levetiracetam is frequently used in the elderly considering its favorable pharmacological profile, efficacy, and good tolerance. We reported an encephalopathy with levetiracetam in an elderly subject who had no renal failure, no concomitant valproate medication, and no other additional co-morbidities. Levetiracetam should be discontinued when this condition is suspected.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s40520-013-0009-x | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!